Cargando…

Novel roles of RNA-binding proteins in drug resistance of breast cancer: from molecular biology to targeting therapeutics

Therapy resistance remains a huge challenge for current breast cancer treatments. Exploring molecular mechanisms of therapy resistance might provide therapeutic targets for patients with advanced breast cancer and improve their prognosis. RNA-binding proteins (RBPs) play an important role in regulat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cen, Yinghuan, Chen, Letian, Liu, Zihao, Lin, Qun, Fang, Xiaolin, Yao, Herui, Gong, Chang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911762/ https://www.ncbi.nlm.nih.gov/pubmed/36759501 http://dx.doi.org/10.1038/s41420-023-01352-x

Ejemplares similares

Attenuation of PITPNM1 Signaling Cascade Can Inhibit Breast Cancer Progression
por: Liu, Zihao, et al.
Publicado: (2021)

MiRNAs and Cancer: Key Link in Diagnosis and Therapy
por: Shi, Yu, et al.
Publicado: (2021)

circCDYL2 promotes trastuzumab resistance via sustaining HER2 downstream signaling in breast cancer
por: Ling, Yun, et al.
Publicado: (2022)

Silencing CTNND1 Mediates Triple-Negative Breast Cancer Bone Metastasis via Upregulating CXCR4/CXCL12 Axis and Neutrophils Infiltration in Bone
por: Lin, Qun, et al.
Publicado: (2021)

MiR-92b-3p Inhibits Proliferation of HER2-Positive Breast Cancer Cell by Targeting circCDYL
por: Liang, Gehao, et al.
Publicado: (2021)

Surmounting Cancer Drug Resistance: New Perspective on RNA-Binding Proteins
por: Feng, Yiyuan, et al.
Publicado: (2023)

Survey of the binding preferences of RNA-binding proteins to RNA editing events
por: Hu, Xiaolin, et al.
Publicado: (2022)

Enhanced anticancer effect of doxorubicin by TPGS-coated liposomes with Bcl-2 siRNA-corona for dual suppression of drug resistance
por: Li, Yinghuan, et al.
Publicado: (2020)

Breast cancer lung metastasis: Molecular biology and therapeutic implications
por: Jin, Liting, et al.
Publicado: (2018)

Therapeutic siRNA for drug-resistant HER2-positive breast cancer
por: Gu, Shenda, et al.
Publicado: (2016)

Molecular Biology Mechanisms and Emerging Therapeutics of Triple-Negative Breast Cancer
por: Zhang, Zhiying, et al.
Publicado: (2023)

RNA in Biology and Therapeutics
por: Jeong, Sunjoo
Publicado: (2023)

Markers of Tumor-Initiating Cells Predict Chemoresistance in Breast Cancer
por: Gong, Chang, et al.
Publicado: (2010)

Considerations and recommendations for assessment of plasma protein binding and drug–drug interactions for siRNA therapeutics
por: Humphreys, Sara C, et al.
Publicado: (2022)

Receptors that bind to PEDF and their therapeutic roles in retinal diseases
por: Xu, Manhong, et al.
Publicado: (2023)

Molecular Engineering of Peptide–Drug Conjugates for Therapeutics
por: Fang, Yu, et al.
Publicado: (2022)

Ethics and Nanopharmacy: Value Sensitive Design of New Drugs
por: Timmermans, Job, et al.
Publicado: (2011)

LncRNA EILA promotes CDK4/6 inhibitor resistance in breast cancer by stabilizing cyclin E1 protein
por: Cai, Zijie, et al.
Publicado: (2023)

Are we ready for therapeutic drug monitoring of biologic therapeutics?
por: Krieckaert, Charlotte LM, et al.
Publicado: (2011)

Molecular and biological functions of gingerol as a natural effective therapeutic drug for cervical cancer
por: Zivarpour, Parinaz, et al.
Publicado: (2021)

Therapeutic drug monitoring of biologics in psoriasis
por: Liau, MeiQi May, et al.
Publicado: (2019)

The Musashi RNA-binding proteins in female cancers: insights on molecular mechanisms and therapeutic relevance
por: Sicking, Mark, et al.
Publicado: (2023)

Cellular receptor binding and entry of human papillomavirus
por: Letian, Tan, et al.
Publicado: (2010)

Small Molecular Inhibitors Reverse Cancer Metastasis by Blockading Oncogenic PITPNM3
por: Liu, Zihao, et al.
Publicado: (2022)

Molecular identification and biological characterization of Cryptosporidium muris from camels (Camelus bactrianus) in China
por: Wang, Luyang, et al.
Publicado: (2021)

Biology of cyclooxygenase-2: An application in depression therapeutics
por: He, Ying, et al.
Publicado: (2022)

Uveal melanoma: progress in molecular biology and therapeutics
por: Li, Yongyun, et al.
Publicado: (2020)

Atherosclerosis: From Molecular Biology to Therapeutic Perspective
por: Perrotta, Ida
Publicado: (2022)

Biology and therapeutic targeting of molecular mechanisms in MPNs
por: How, Joan, et al.
Publicado: (2023)

Molecular Structure, Binding Affinity, and Biological Activity in the Epigenome
por: Zsidó, Balázs Zoltán, et al.
Publicado: (2020)

RNA-binding proteins as targets for pain therapeutics
por: de la Peña, June Bryan, et al.
Publicado: (2018)

Role of Molecular Targeted Therapeutic Drugs in Treatment of Breast Cancer: A Review Article
por: Singh, Himanshu
Publicado: (2023)

Molecular biology of breast tumors and prognosis
por: Baldassarre, Gustavo, et al.
Publicado: (2016)

Editorial: The molecular mechanisms of metastasis and therapeutic resistance in breast cancer
por: Liang, Yuanke, et al.
Publicado: (2023)

Incorporating MicroRNA into Molecular Phenotypes of Circulating Tumor Cells Enhances the Prognostic Accuracy for Patients with Metastatic Breast Cancer
por: Tan, Weige, et al.
Publicado: (2019)

Posttranscriptional Regulation and RNA Binding Proteins in Cancer Biology
por: Ghigna, Claudia, et al.
Publicado: (2015)

Drug Discovery Toward Antagonists of Methyl-Lysine Binding Proteins
por: Herold, J. Martin, et al.
Publicado: (2011)

MicroRNA-Based Discovery of Biomarkers, Therapeutic Targets, and Repositioning Drugs for Breast Cancer
por: Ye, Qing, et al.
Publicado: (2023)

MicroRNA-Based Therapeutics for Drug-Resistant Colorectal Cancer
por: Jung, Eunsun, et al.
Publicado: (2021)

Molecular Mechanisms of Pharmaceutical Drug Binding into Calsequestrin
por: Subra, Arun K., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_70023e5d7l8kgf9rhumvi5vve3